Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
No Data
VTEX Transcript
VTEX (VTEX) Q1 2026 Earnings Call Transcript
Unknown5-8
The earnings call presents a mixed picture. Despite strong financial metrics like increased subscription revenue, gross margins, and cash flow, guidance reduction due to macro challenges in Brazil and cautious AI product contributions temper enthusiasm. The Q&A highlights ongoing challenges with macro conditions, elongated sales cycles, and unclear AI monetization strategies. However, positive signs include strong global market growth and B2B traction. Given the small-cap nature of the company, the stock might experience mild fluctuations, but the overall sentiment remains neutral due to balanced positive and negative factors.
VTEX (VTEX) Q4 2025 Earnings Call Transcript
Positive2-27
The earnings call reveals strong financial performance with a 25% revenue increase and improved gross margins, indicating operational efficiency. Net income turned positive, and free cash flow increased, reflecting better profitability and financial health. While forward-looking statements carry risks, the guidance for subscription revenue growth and operational margins is optimistic. Given the small market cap, these positive financial metrics and optimistic guidance are likely to lead to a stock price increase of 2% to 8% over the next two weeks.
VTEX (VTEX) Q3 2025 Earnings Call Transcript
Positive11-6
The earnings call highlights strong financial performance, with significant growth in non-GAAP net income and gross margins. The company is expanding globally, particularly in the U.S. and Europe, and increasing R&D for AI integration. Despite challenges in Argentina and LatAm, the company maintains stable churn and a positive outlook. The raised guidance for non-GAAP income and free cash flow, along with strong U.S. operations, supports a positive sentiment. The market cap suggests a moderate reaction, leading to a 'Positive' prediction for stock price movement.
VTEX (VTEX) Q2 2025 Earnings Call Transcript
Unknown8-8
The earnings call presents mixed signals. Strong financial metrics such as increased gross profit, operating income, and cash flow indicate positive performance. However, the decline in guidance due to challenges in Argentina and Brazil, combined with competitive pressures in mature markets, tempers enthusiasm. The Q&A reveals concerns about regional volatility and cautious outlooks, balancing the positives with uncertainties. Given the company's market cap, the stock is likely to experience a neutral reaction in the short term, with potential fluctuations as investors digest the guidance and regional challenges.
Frequently Asked Questions
Where does this earnings call transcript come from?
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
How soon is the transcript available after the earnings call ends?
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
Is the transcript edited or altered in any way?
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
Why do some answers appear as “Unclear” or “Inaudible”?
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
Who creates the AI Summary and Key Q&A highlights shown above the transcript?
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
